China Pharma Holdings
CPHI
6 hedge funds and large institutions have $767K invested in China Pharma Holdings in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
48% more capital invested
Capital invested by funds: $518K → $767K (+$249K)
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$116K |
| 2 |
HF
HRT Financial
New York
|
+$29.4K |
| 3 |
TI
tru Independence
Portland,
Oregon
|
+$6.17K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$5.92K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$55.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$23.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$11K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $558K | -$55.3K | -224 | -12% |
|
|
BCM
2
Bridgeway Capital Management
Houston,
Texas
| $157K | +$116K | +470 | New |
|
|
HF
3
HRT Financial
New York
| $39K | +$29.4K | +119 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $8K | +$5.92K | +24 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $5K | -$23.7K | -96 | -86% |
|
|
TI
6
tru Independence
Portland,
Oregon
| $8 | +$6.17K | +25 | New |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$11K | -44 | Closed |
|
CPHI Hedge Fund Activity: Q2 2020 in Review
6 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2020, worth a combined $767K — up 48% from $518K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CPHI positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $116K. The largest seller was Renaissance Technologies, cutting an estimated $55.3K.
- 6 institutional investors held China Pharma Holdings (CPHI) as of Q2 2020, up from 3 in Q1 2020.
- Funds reported $767K of China Pharma Holdings stock for Q2 2020, up 48% quarter-over-quarter.
- 4 funds opened new China Pharma Holdings positions in Q2 2020 and 1 closed out, a net change of +3 holders.
- The largest China Pharma Holdings buyer in Q2 2020 was Bridgeway Capital Management, an estimated $116K added.
- The largest China Pharma Holdings seller in Q2 2020 was Renaissance Technologies, an estimated $55.3K sold.
Based on aggregated 13F filings for Q2 2020.